P22-1 Nivolumab combination chemotherapy (NC) for HER2-negative, unresectable, advanced, or recurrent gastric cancer (AGC): A retrospective observational study
Wakana Chikaishi(Gifu University), Nobuhisa Matsuhashi(Gifu University), Naoki Okumura(Doshisha University), Shigeru Kiyama(Gifu University), Akitaka Makiyama(Gifu University Hospital), Takuji Iwashita(Gifu University Hospital), Yoshihiro Tanaka(Kyushu University Hospital), Hirokatsu Hayashi(Gifu University), Chinatsu Makiyama(Gifu University Hospital), Itaru Yasufuku(Gifu University), Ryuichi Asai(Gifu University), Jesse Yu Tajiama(Gifu University Hospital), Takao Takahashi(Maruyama Memorial General Hospital), Hiroshi Tsuchiya(Gifu University), Yuta Sato(Gifu University), Shinya Uemura(Gifu University Hospital), Katsutoshi Murase(Gifu University), Takashi Ibuka(Gifu University), Masahito Shimizu(Gifu University Hospital)
Cited by 1
Related Papers
The cell cycle of the pseudostratified ventricular epithelium of the embryonic murine cerebral wall
|Journal of Neuroscience|1995|672
Injection of Cultured Cells with a ROCK Inhibitor for Bullous Keratopathy
|New England Journal of Medicine|2018|551
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020
|Journal of Gastroenterology|2021|424
Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies
|Nature Medicine|2020|366
The Leaving or Q Fraction of the Murine Cerebral Proliferative Epithelium: A General Model of Neocortical Neuronogenesis
|Journal of Neuroscience|1996|334